Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 28, 2015 19:33 ET | Source: Qu Biologics

Qu Biologics Begins Phase 2 Clinical Trial in Ulcerative Colitis

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 28, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
July 14, 2015 09:00 ET | Source: Qu Biologics

Qu Biologics Begins Research Collaboration with Dr. Bruce Vallance at the University of British Columbia to Study SSI Treatment for Inflammatory Bowel Disease

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 14, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
June 10, 2015 09:40 ET | Source: Qu Biologics

Qu Biologics Appoints Jim Pankovich as Vice President, Clinical Operations and Drug Development

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 10, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
May 11, 2015 10:05 ET | Source: Qu Biologics

Qu Biologics Granted European Patent for Use of Bacterial Compositions for the Treatment of Cancer

VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 11, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
April 30, 2015 15:31 ET | Source: Qu Biologics

Qu Biologics to Present at Bloom Burton Healthcare Investor Conference

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 30, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
April 24, 2015 15:05 ET | Source: Qu Biologics

Qu Biologics Opens Clinical Trial Sites in Edmonton and Toronto for Crohn's Disease Clinical Trial

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 24, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
March 31, 2015 09:40 ET | Source: Qu Biologics

Qu Biologics Granted U.S. Patent for Use of E. coli to Treat Crohn's Disease

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 31, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
March 24, 2015 10:00 ET | Source: Qu Biologics

Qu Biologics Begins Research Collaboration with the University of Rochester, New York

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 24, 2014) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
March 04, 2015 10:00 ET | Source: Qu Biologics

Qu Biologics Named Life Sciences BC Growth Stage Company of the Year

VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 4, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
February 04, 2015 10:05 ET | Source: Qu Biologics;BC Cancer Agency

Qu Biologics Enrolls First Two Participants in Phase 2a Clinical Trial for Lung Cancer

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 4, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right